FDA UDI
In Commercial Distribution
🇺🇸 United States
UScreen Oral
DI: 00850065976280
·
Model: USSORAL-5NT-EUO
·
Guangzhou Decheng Biotechnology Co., LTD
Product Codes
9
GMDN Terms
9
Identifiers
2
Pkg Device Count
25
Let the assistant research this device
The Research Assistant compiles product codes, classification, clearances and adverse events for this device — and cites every record.
Free to try · every answer cites its records
Basic Information
- Brand Name
- UScreen Oral
- Primary DI
- 00850065976280
- Version / Model
- USSORAL-5NT-EUO
- Company Name
- Guangzhou Decheng Biotechnology Co., LTD
- Labeler DUNS
- 554534314
- Distribution Status
- In Commercial Distribution
- Device Count in Pkg
- 25
- Record Status
- Published
- Publish Date
- 2024-09-27
- Public Version
- 1
- Public Version Date
- 2024-10-07
- Public Version Status
- New
- Public Device Record Key
- 0844a914-fd63-4f03-b9b0-f23a51e61040
Device Description
UScreen Oral® Saliva Drug Test Pen, 5 Panel, 25T/Box
Device Characteristics
- Single Use
- Yes
- Prescription Use (Rx)
- No
- Over the Counter (OTC)
- No
- Kit
- No
- Combination Product
- No
- HCT/P
- No
- Contains NRL
- No
- Not Made with NRL
- No
- MRI Safety
- Labeling does not contain MRI Safety Information
- Direct Marking Exempt
- No
- PM Exempt
- Yes
- Has Serial Number
- No
- Has Lot/Batch Number
- Yes
- Has Manufacturing Date
- No
- Has Expiration Date
- Yes
- Has Donation ID
- No
Sterilization
- Is Sterile
- No
- Sterilization Prior Use
- No
Product Codes
| Code | Name | Medical Specialty | Regulation # | Device Class |
|---|---|---|---|---|
| PUX | Test, Amphetamine, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3100 | 2 |
| PUY | Test, Barbiturate, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3150 | 2 |
| PUZ | Test, Benzodiazepine, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3170 | 2 |
| PVA | Test, Cocaine And Cocaine Metabolite, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3250 | 2 |
| MRS | Test System, Nicotine, Cotinine, Metabolites | Clinical Toxicology | 862.3220 | 1 |
| PVJ | Test, Cannabinoid, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3870 | 2 |
| PVE | Test, Methadone, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3620 | 2 |
| PVD | Test, Methamphetamine, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3610 | 2 |
| PVH | Test, Opiates, Employment And Insurance Testing, Exempt | Clinical Toxicology | 862.3650 | 2 |
GMDN Terms
| Code | Name | Definition | Implantable | Status |
|---|---|---|---|---|
| 30516 | Amphetamine-specific IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of a specific amphetamine in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
| 30517 | Barbiturate IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of barbiturates in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
| 30518 | Benzodiazepine group IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of benzodiazepine in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
| 30519 | Cannabinoid/cannabinoid metabolite IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of cannabinoids and/or cannabinoid metabolites (i.e., natural, synthetic) in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
| 30520 | Cocaine/cocaine metabolite IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of cocaine and/or cocaine metabolites in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
| 30521 | Methadone IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of methadone in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
| 30522 | Opiate/opiate metabolite IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of opiate and/or opiate metabolites in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
| 55498 | Methamphetamine-specific IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of a specific methamphetamine in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
| 64155 | Cotinine IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of cotinine (nicotine metabolite) in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses to aid in the differentiation of smokers and non-smokers, or in the investigation of the link between smoking and associated disorders (e.g., cancer, coronary heart disease, stroke). It is not intended to be used for self-testing. | No | Active |
Identifiers
| Type | ID | Issuing Agency | Package Type | Qty per Pkg | Pkg Status | Pkg Discontinue Date |
|---|---|---|---|---|---|---|
| Unit of Use | 30850065976281 | GS1 | ||||
| Primary | 00850065976280 | GS1 |